Tags

Type your tag names separated by a space and hit enter

Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Sci Rep. 2019 Nov 22; 9(1):17729.SR

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Links

PMC Free PDF

Authors+Show Affiliations

Costamagna A
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Rossi Sebastiano M
Institut für Pharmacologie, Universität Bern, Inelspital INO-F, CH-3010, Bern, Switzerland.
Natalini D
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Simoni M
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Valabrega G
Candiolo Cancer Institute, FPO - IRCCS -, Candiolo, (TO), 10060, Italy.
Defilippi P
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Visentin S
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Ermondi G
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Turco E
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Caron G
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
Cabodi S
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy. sara.cabodi@unito.it.

Pub Type(s)

Published Erratum

Language

eng

PubMed ID

31758081

Citation

Costamagna, Andrea, et al. "Author Correction: Modeling ErbB2-p130Cas Interaction to Design New Potential Anticancer Agents." Scientific Reports, vol. 9, no. 1, 2019, p. 17729.
Costamagna A, Rossi Sebastiano M, Natalini D, et al. Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. Sci Rep. 2019;9(1):17729.
Costamagna, A., Rossi Sebastiano, M., Natalini, D., Simoni, M., Valabrega, G., Defilippi, P., Visentin, S., Ermondi, G., Turco, E., Caron, G., & Cabodi, S. (2019). Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. Scientific Reports, 9(1), 17729. https://doi.org/10.1038/s41598-019-54252-5
Costamagna A, et al. Author Correction: Modeling ErbB2-p130Cas Interaction to Design New Potential Anticancer Agents. Sci Rep. 2019 Nov 22;9(1):17729. PubMed PMID: 31758081.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents. AU - Costamagna,Andrea, AU - Rossi Sebastiano,Matteo, AU - Natalini,Dora, AU - Simoni,Matilde, AU - Valabrega,Giorgio, AU - Defilippi,Paola, AU - Visentin,Sonja, AU - Ermondi,Giuseppe, AU - Turco,Emilia, AU - Caron,Giulia, AU - Cabodi,Sara, Y1 - 2019/11/22/ PY - 2019/11/24/entrez PY - 2019/11/24/pubmed PY - 2019/11/24/medline SP - 17729 EP - 17729 JF - Scientific reports JO - Sci Rep VL - 9 IS - 1 N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper. SN - 2045-2322 UR - https://www.unboundmedicine.com/medline/citation/31758081/Author_Correction:_Modeling_ErbB2_p130Cas_interaction_to_design_new_potential_anticancer_agents_ DB - PRIME DP - Unbound Medicine ER -